Elanco Animal Health Incorporated

DB:5EA Stock Report

Market Cap: €5.7b

Elanco Animal Health Management

Management criteria checks 3/4

Elanco Animal Health's CEO is Jeff Simmons, appointed in Jul 2018, has a tenure of 6.5 years. total yearly compensation is $13.66M, comprised of 8.8% salary and 91.2% bonuses, including company stock and options. directly owns 0.23% of the company’s shares, worth €13.03M. The average tenure of the management team and the board of directors is 6.1 years and 5.8 years respectively.

Key information

Jeff Simmons

Chief executive officer

US$13.7m

Total compensation

CEO salary percentage8.8%
CEO tenure6.5yrs
CEO ownership0.2%
Management average tenure6.1yrs
Board average tenure5.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Jeff Simmons's remuneration changed compared to Elanco Animal Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$205m

Jun 30 2024n/an/a

-US$1b

Mar 31 2024n/an/a

-US$1b

Dec 31 2023US$14mUS$1m

-US$1b

Sep 30 2023n/an/a

-US$1b

Jun 30 2023n/an/a

-US$113m

Mar 31 2023n/an/a

-US$26m

Dec 31 2022US$13mUS$1m

-US$78m

Sep 30 2022n/an/a

-US$132m

Jun 30 2022n/an/a

-US$171m

Mar 31 2022n/an/a

-US$371m

Dec 31 2021US$12mUS$1m

-US$483m

Sep 30 2021n/an/a

-US$698m

Jun 30 2021n/an/a

-US$729m

Mar 31 2021n/an/a

-US$572m

Dec 31 2020US$9mUS$1m

-US$574m

Sep 30 2020n/an/a

-US$246m

Jun 30 2020n/an/a

-US$101m

Mar 31 2020n/an/a

-US$13m

Dec 31 2019US$16mUS$1m

US$68m

Sep 30 2019n/an/a

US$94m

Jun 30 2019n/an/a

US$144m

Mar 31 2019n/an/a

US$45m

Dec 31 2018US$5mUS$775k

US$87m

Compensation vs Market: Jeff's total compensation ($USD13.66M) is above average for companies of similar size in the German market ($USD3.29M).

Compensation vs Earnings: Jeff's compensation has been consistent with company performance over the past year.

CEO

Jeff Simmons (57 yo)

6.5yrs

Tenure

US$13,663,169

Compensation

Mr. Jeffrey N. Simmons, also known as Jeff, serves as President and Chief Executive Officer at Elanco Animal Health Incorporated since July 2018 and its Director since September 2018. Mr. Simmons serves as...

Leadership Team

NamePositionTenureCompensationOwnership
Jeffrey Simmons
President6.5yrsUS$13.66m0.23%
€ 13.0m
Todd Young
Executive VP & CFO6.2yrsUS$3.73m0.035%
€ 2.0m
Ramiro Cabral
Executive Vice President of Elanco International6.5yrsUS$2.65m0.022%
€ 1.3m
Ellen de Brabander
Executive Vice President of Research3.3yrsUS$3.68m0.0097%
€ 555.2k
Timothy Bettington
Executive Vice President of Corporate Strategy & Market Development1.8yrsUS$2.19m0.017%
€ 982.7k
James Meer
Senior VP & Chief Accounting Officer6.3yrsno data0.0054%
€ 312.6k
Chris Keeley
Senior VP & Chief Information Officerno datano datano data
David Kinard
Executive Vice President of Human Resources6yrsUS$2.85m0.024%
€ 1.4m
Katy Grissom
Head of Investor Relationsno datano datano data
Shiv O'Neill
Executive Vice President2yrsno data0.0048%
€ 276.4k
Larbi Lier
Senior Vice President of Asiano datano datano data
Shabbir Simjee
Chief Medical Officerno datano datano data

6.1yrs

Average Tenure

53yo

Average Age

Experienced Management: 5EA's management team is seasoned and experienced (6.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jeffrey Simmons
President6.3yrsUS$13.66m0.23%
€ 13.0m
William Doyle
Independent Director4.1yrsUS$330.01k0.0061%
€ 348.8k
Roy Hoover
Independent Director6.3yrsUS$496.01k0.044%
€ 2.5m
Paul Herendeen
Independent Director4.1yrsUS$330.01k0.0020%
€ 116.1k
Lawrence Kurzius
Independent Chairman6.3yrsUS$350.01k0.0020%
€ 116.1k
Art Garcia
Independent Director5.7yrsUS$330.01k0.00071%
€ 40.8k
Denise Scots-Knight
Independent Director5.8yrsUS$330.01kno data
John Paul Bilbrey
Independent Director5.8yrsUS$346.01k0.0084%
€ 485.1k
Deborah Kochevar
Independent Director5.8yrsUS$346.01k0.00020%
€ 11.5k
Kirk McDonald
Independent Director5.8yrsUS$330.01kno data
Michael Harrington
Independent Director6.3yrsUS$330.01k0.0040%
€ 227.6k
Kapila Anand
Independent Director6.3yrsUS$355.01k0.00065%
€ 37.4k

5.8yrs

Average Tenure

65.5yo

Average Age

Experienced Board: 5EA's board of directors are considered experienced (5.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/04 08:36
End of Day Share Price 2024/12/11 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Elanco Animal Health Incorporated is covered by 28 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jasper HellwegArgus Research Company
Ishan MajumdarBaptista Research
Balaji PrasadBarclays